Loading...
$3.0M
Awarded Sep 14, 2026
Competition
FULL AND OPEN COMPETITION
Offers
N/A
Set-Aside
None
Solicitation Type
RFP - Negotiated
Performance Timeline
Start
Sep 14, 2026
Estimated start: Sep 13, 2029
Contract: 75F40126F19003
UEI
MBT9RXJJ7428
Parent Company
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$3,017,553
Base + Exercised Options
$3,017,553
Total Ceiling Value
$3,017,553
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40123D00039
IDCDepartment of Health and Human Services
Award Type: SINGLE AWARD